Von Roemeling, R External Entity

Publications

Sort by

Selected publications

  • Phase II study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small-cell lung cancer.  Annals of Oncology1997 Academic Article GET IT
    Times cited: 49

Other